We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

Genmab is discontinuing development of acasunlimab after a pipeline review, pivoting focus to other oncology antibodies.

Rare inherited genetic variants significantly increase familial lung cancer risk, offering new targets for early detection.

The Lung Cancer Research Foundation® (LCRF) recently awarded five new research grants in the following areas: three LCRF ...

Belfast-based biotech company Biomarx has raised £700,000 in pre-seed funding to progress the development of a diagnostics ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

Lung cancer continues to have a profound impact on many communities, but the disparity is especially notable within Black populations. In these communities, lung cancer incidence and mortality rates ...

Most people associate lung cancer primarily with smoking, but growing evidence suggests diet plays a more significant role than previously thought. While numerous foods help protect against cancer, ...

Lung cancer has been widely perceived as a disease that predominantly affects men. However, recent epidemiological data indicate that it is increasingly being diagnosed in women. In fact, a large ...